Who invested in TargImmune Therapeutics?
TargImmune Therapeutics's investors include EISMEA.

Switzerland · Venture startup
Funding summaryUpdated 26 Oct 2026
$19Mraised across 1 round since 2021, from 1 source
TargImmune Therapeutics's investors include EISMEA.
TargImmune Therapeutics has raised $19M across 1 round since 2021.
TargImmune Therapeutics's most recent round was a Venture of $19M in Jul 2021.
Its most recent round, $19M in Jul 2021, is also its largest on record.
TargImmune Therapeutics's first round on record, in Jul 2021, was backed by EISMEA.
TargImmune Therapeutics's latest named round is a Venture, in Jul 2021.
TargImmune Therapeutics is based in Switzerland.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.